BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Stiefel Laboratories Launches Most-Prescribed BPO Wash Formulations Over-the-Counter


2/4/2011 11:21:18 AM

RESEARCH TRIANGLE PARK, N.C., Feb. 4, 2011 /PRNewswire/ -- Stiefel, a GSK company, today announced the launch of the most-prescribed BPO Acne Wash formulations for over-the-counter (OTC) use in the United States. The launch will occur in the technical exhibit at the American Academy of Dermatology annual meeting in New Orleans. Indicated for the treatment of acne, Stiefel will market two products OTC under the PanOxyl® Brand. PanOxyl® Acne Creamy Wash will be available in 4% BPO and 8% BPO.

PanOxyl® 4% and 8% BPO Acne Creamy Washes feature a patented delivery system including Dimethyl Isosorbide (DMI) that solubilizes BPO and greatly reduces particulate-based skin irritation and inflammation commonly experienced with conventional BPO formulations. Both products are thick, creamy formulations which provide excellent efficacy and rapid reduction in acne lesions.

"Stiefel's Creamy Wash formulations have been physician favorites for several years," said Shayne Sundholm, vice president, U.S. Non Prescription Dermatology, Stiefel. "And we are excited to be able to offer them to a larger number of consumers through the retail market."

A comprehensive marketing campaign directed toward dermatologists and pharmacists will communicate details of the new PanOxyl® 4% and 8% BPO Acne Creamy Washes. Product will be available for shipment in May 2011.

PanOxyl® Acne Management product line offers different formulations for the treatment and prevention of acne on the face, chest and back.

www.panoxyl-skincare.com

About Stiefel, a GSK company

Stiefel, a GSK company, is committed to advancing dermatology and skin science around the world in order to help people better achieve healthier skin. Stiefel's dedication to innovation, along with its focus on pharmaceutical, over-the-counter and aesthetic dermatology products, has established Stiefel as a world leader in the skin health industry. To learn more about Stiefel, visit www.stiefel.com

SOURCE Stiefel, a GSK company



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES